Navigation Links
Inhibikase Therapeutics Elects Steven C. Gilman, Ph.D., to Board of Directors
Date:5/17/2011

ATLANTA, May 17, 2011 /PRNewswire/ -- Inhibikase Therapeutics, Inc. today announced the election Dr. Steven C. Gilman to the Board of Directors of Inhibikase Therapeutics, Inc.

(Logo: http://photos.prnewswire.com/prnh/20110517/CL02791LOGO)

Dr. Steven Gilman joined Cubist Pharmaceuticals in 2008 and currently serves as the Cubist's Executive Vice President, Research & Development and Chief Scientific Officer. Before joining Cubist Pharmaceuticals, Dr. Gilman held several positions with ActivBiotics, Inc., including Chairman of the board of directors and President and CEO. Previously Dr. Gilman worked at Millennium Pharmaceuticals, Inc., where he held a number of senior leadership roles including Vice President and General Manager, Inflammation. Additionally, Dr. Gilman served as Group Director at Pfizer Global Research and Development, where he was responsible for drug discovery of novel antibacterial agents as well as several other therapeutic areas.

Dr. Gilman currently serves on the Boards of Directors of the Massachusetts Biotechnology Association and the Massachusetts Society for Medical Research. In addition, Dr. Gilman serves on the Science and Regulatory Executive Committee of PhRMA. Dr. Gilman received his Ph.D. and M.S. degrees in microbiology from Pennsylvania State University, his post-doctoral training at Scripps Clinic and Research Foundation, and received a B.A. in microbiology from Miami University of Ohio.

Dr. Gilman joins Board members Dr. Stephen Fesik, Orrin H. Ingram, II Chair in Cancer Research at Vanderbilt University and former Vice-President for Cancer Research, Abbott Laboratories, Mr. David Gryska, former CFO of Celgene and Ms. Lisa Evren, Vice-President and Treasurer, Talisman-Energy.

"We are fortunate to add Dr. Gilman to the slate of new Board members elected in the last eight months.  Dr. Gilman's breadth of experience in pharmaceutical development and senior leadership will acceler
'/>"/>

SOURCE Inhibikase Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Inhibikase Therapeutics Discusses New Platform for Infectious Disease Pharmaceuticals at BIOCOM 2009
2. Echo Therapeutics Appoints Christopher P. Schnittker as Chief Financial Officer
3. Healthpoint Biotherapeutics Introduces OASIS® Ultra Tri-Layer Matrix
4. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
5. Orexigen® Therapeutics Reports First Quarter Ended March 31, 2011 Financial Results
6. Cell Therapeutics Announces Planned Reverse Stock Split; Receives NASDAQ Notice of Non-Compliance; Intends to Request Hearing
7. Echo Therapeutics Expands Into New Headquarters in Philadelphia
8. Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
9. Halozyme Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference on May 12
10. Amicus Therapeutics Announces First Quarter 2011 Financial Results and Continued Progress of Development Programs
11. Nile Therapeutics Announces Dosing of First Patient in Phase I Study of Cenderitide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... NEW YORK, May 6, 2015 Delcath Systems, ... medical device company focused on oncology with an emphasis ... announces financial results for the three months ended March ... quarter and recent weeks include: , Achieved quarterly ... than 43% compared with the first quarter of 2014; ...
(Date:5/6/2015)... , May 6, 2015 CVS Health (NYSE: CVS ... Baltimore locations that sustained heavy fire damage during ... in Baltimore over the past week or ... is ahead," said CVS Health President and CEO Larry Merlo ... path to better health. There is no better way that we ...
(Date:5/6/2015)... Fibich, Leebron, Copeland, Briggs & Josephson is ... been reached to resolve lawsuits involving individuals who were ... - manufactured by Takeda Pharmaceuticals - has been associated ... of the firm,s attorneys were instrumental in the coordination ... Fibich - Founding Partner of Fibich, Leebron, Copeland, ...
Breaking Medicine Technology:Delcath Reports 2015 First Quarter Financial Results 2Delcath Reports 2015 First Quarter Financial Results 3Delcath Reports 2015 First Quarter Financial Results 4Delcath Reports 2015 First Quarter Financial Results 5Delcath Reports 2015 First Quarter Financial Results 6Delcath Reports 2015 First Quarter Financial Results 7Delcath Reports 2015 First Quarter Financial Results 8CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2Takeda Agrees to $2.4 Billion Settlement for Actos Bladder Cancer Lawsuits 2
... JERSEY CITY, N.J., May 2, 2011 Aoxing ... Pharma"), a specialty pharmaceutical company focusing on research, ... products, announced that its operating subsidiary in China, ... a patent by the State Intellectual Property Office ...
... International, Inc. (NYSE: VRX ) (TSX: VRX) today ... and Cephalon, Inc. (NASADQ: CEPH) on their announcement that Cephalon ... the news, Valeant has withdrawn its consent solicitation. ... Cephalon stockholders and we are pleased that Teva has paid ...
Cached Medicine Technology:Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film 2Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film 3Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction 2
(Date:5/6/2015)... 06, 2015 As Hilo Medical ... EMR Adoption Model, the hospital looked for new ... and automate processes. The leadership team realized that ... electronic workflows, patient registration still required patients to ... With HIMSS Stage 7 attestation fast approaching, Hilo ...
(Date:5/6/2015)... Experienced Vancouver air conditioning installation and repair ... will now conduct their cooling services, including air conditioning ... commercial and residential units. Strata complex air conditioning services ... technical knowledge as well as a professionally trained staff. ... take away any old air conditioning unit to be ...
(Date:5/6/2015)... Vancouver, BC (PRWEB) May 06, 2015 ... colon hydrotherapy supplier, is excited to announce a ... will help reduce the industry’s carbon footprint while ... These kits feature Eco-Flex™, the world’s ... “This is a game-changer for hydrotherapists,” claims the ...
(Date:5/6/2015)... Animals make just as good friends as they do ... health. An Ohio veterinarian has been observing this ... health advantages of owning a pet. , “When animals and ... ownership, there are proven health benefits for people-- including physical, ... the Animal Medical Center of Streetsboro said. Every ...
(Date:5/6/2015)... Inversion Studios, a full-service training ... Pilates classes, provides personalized individual instruction and now ... its new Pilates Ring magic circle. , Inversion ... stronger, more centered and graceful, Inversion Studios and ... to healthy fitness through yoga and Pilates. With ...
Breaking Medicine News(10 mins):Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3
... than that, after a lumpectomy for breast cancer. Researchers from ... ubiquitous tummy fat , can in fact be used to ... two birds with one stone, a flatter belly and a ... a 'supercharged' fat mixture into the breast tissue after it ...
... a genetic marker that increases a person's risk of colon ... 10-year study was conducted by a team of researchers from ... Public Health, the Catalan Institute of Oncology in Spain, the ... Israel Institute of Technology, including Stephen Gruber and Gad Rennert. ...
... announced today that ALIGN(R) is now available through ... builds and maintains a natural defense against ... as constipation, diarrhea, abdominal discomfort, urgency, gas and ... contains Bifantis(R) (Bifidobacterium infantis 35624), a natural probiotic ...
... western media, the government of the Peoples Republic of China ... the countrys Food and Drug Administration. ,,He was ... of dereliction of duty at a trial in May. ... led to several deaths. , ,China has been ...
... Microsoft, aware that a large number of Internet searches ... presence in the healthcare sector . This, claims Cambridge ... healthcare professionals and medical device manufacturers. According to a ... are already having to come to terms with informed ...
... to detect a disease in its very early ... slowly gaining greater acceptance across Europe . Furthermore, ... and invasive procedures, in addition to reducing bed ... Europe, age-related diseases such as cancer, Alzheimer's disease, ...
Cached Medicine News:Health News:Stem Cells In Belly Fat To Enhance Or Reconstruct Breasts 2Health News:Food Safety Chief Executed for Bribery in China 2Health News:Food Safety Chief Executed for Bribery in China 3Health News:Food Safety Chief Executed for Bribery in China 4Health News:Battle Between Google and Microsoft Could Trigger Revolution in Healthcare 2Health News:Pharmacogenomic Market Gaining Greater Acceptance Across Europe 2Health News:Pharmacogenomic Market Gaining Greater Acceptance Across Europe 3
QC 900 is an assayed quality control material for analyzers measuring hematocrit by electrical conductivity methodologies. It is available in two (2) levels for monitoring analyzer performance at var...
... 823 is an assayed quality ... the performance of blood gas, ... instrumentation. It is available in ... analyzer performance at varying points ...
... QC 463 is a quality control ... monitoring the performance of blood gas, electrolyte, ... practical alternative to the use of human ... in three (3) levels for monitoring analyzer ...
... and probe system used together to quantify ... based system is a sandwich nucleic acid ... for RNA detection and quantification, by amplifying ... technology. Branched DNA allows immediate quantification of ...
Medicine Products: